The expression of activated mutants of M-Ras (G22V or Q71L), but not wild-type M-Ras, in a murine mammary epithelial cell line, scp2, resulted in epithelial-mesenchymal transition (EMT) and oncogenic transformation. Cells expressing constitutively active M-Ras continued to grow in the absence of serum and exhibited a loss of the epithelial markers cytokeratin, E-cadherin and b-catenin, together with a gain of the mesenchymal marker vimentin, a loss of contact inhibition in monolayer growth and a gain of the capacity for anchorage-independent growth. Moreover, unlike the parental cells, they failed to form differentiated mammospheres on Matrigel and instead formed branched networks of cells that grew and invaded the Matrigel. The expression of activated p21 Ras (G12V H-Ras or Q61K N-Ras) also resulted in EMT and tumorigenesis, although there was evidence that expression of higher levels was toxic. Tumors derived from scp2 cells expressing activated M-Ras exhibited activation of Akt and of ERK. The levels of expression of Q71L M-Ras and G12V H-Ras required for tumorigenesis were comparable, although higher levels of the weaker G22V M-Ras mutant were selected for in vivo. These data indicate that the expression of activated mutants of MRas was sufficient for oncogenic transformation of a murine mammary epithelial cell line.
Introduction
The Ras subfamily of small GTPases consists of 13 closely related proteins and can be further divided into five subgroups, each defined by orthologous proteins in C. elegans (Ehrhardt et al., 2002) . The first of these contains the four classical p21 Ras proteins, Harvey-Ras (H-Ras), neuroblastoma-Ras (N-Ras) and two splice variants of Kirsten-Ras (K-Ras4A and K-Ras 4B). These share about 85% amino-acid sequence identity and have been extensively studied because constitutively activated mutants of these proteins occur in many types of human cancer (Bos, 1988) . The other four subgroups consist of the Rap (Noda, 1993) , Ral (Urano et al., 1996) and R-Ras (Lowe et al., 1987; Chan et al., 1994) protein families together with M-Ras (Kimmelman et al., 1997; Matsumoto et al., 1997; Ehrhardt et al., 1999; Louahed et al., 1999; Quilliam et al., 1999) . While the proteins in these groups share only 40-50% overall amino-acid identity, they are highly conserved in the key switch I and switch II regions that are critical for interactions with effector proteins, the activating guanine-nucleotide exchange factors (GEFs) and the negatively regulating GTPase-activating proteins (GAPs) (Ehrhardt et al., 1999; Ohba et al., 2000; Quilliam et al., 2001) . These strong similarities result in a great deal of overlap in their regulation and functions (Ehrhardt et al., 2002) . Moreover, these similarities mean that research tools like the monoclonal antibody Y13-259 and dominant-negative mutants of p21 Ras can no longer be assumed to provide information specific for p21 Ras (Ehrhardt et al., 2002) .
While the oncogenic activity of activated mutants of p21 Ras has been studied extensively, less is known of the oncogenic potential of other members of the family. One-third of all solid tumors have activating mutations in the classical p21 Ras genes (Bos, 1989) , but these occur in less than 5% of breast cancers (Miyakis et al., 1998) . This raises the possibility that other members of the Ras subfamily might have a role in the transformation of mammary epithelial cells (Barker and Crompton, 1998) . Overexpression of activated mutants of R-Ras or R-Ras-2 resulted in the transformation of fibroblasts and in the case of R-Ras-2, human mammary cells (Cox et al., 1994; Clark et al., 1996) . Overexpression of activated mutants of M-Ras resulted in the transformation of fibroblasts (Kimmelman et al., 1997; Ehrhardt et al., 1999; Quilliam et al., 1999) and hematopoietic cells (Ehrhardt et al., 1999; Louahed et al., 1999) .
Analysis of the transforming ability of different members of the Ras subfamily is complicated by evidence that activated p21 Ras utilizes different signaling mechanisms to transform fibroblasts from mice and humans (Hamad et al., 2002) . Thus, while transformation of murine fibroblasts by activated p21 Ras was mediated by activation of Raf-1, this was not the case with human fibroblasts, or epithelial cells, where transformation was mediated by Ral-GDS. Moreover, in rodents, the signaling mechanisms downstream of activated p21 Ras that mediates transformation differ in different types of cells. Thus, in contrast to results with murine 3T3-fibroblasts, in a rat intestinal epithelial cell-line expression of a constitutively activated Raf-1 was insufficient for transformation. This required an additional signal downstream of activated H-Ras that could be mimicked by pharmacological inhibition of p38 MAP kinase (Pruitt et al., 2002) . Given that M-Ras is widely expressed in many tissues and cells, including cell lines from human breast cancers, and binds only weakly to Raf-1 (Kimmelman et al., 1997; Ehrhardt et al., 1999) , we were interested in assessing the potential of activated M-Ras to transform mammary epithelial cells.
We therefore investigated the effects of expressing activated mutants of M-Ras in a well-differentiated murine mammary epithelial cell line, scp2 (Desprez et al., 1993) . This cell line was derived from mid-gestational mammary tissue (Desprez et al., 1993) and exhibits many characteristics of normal epithelial cells, such as expression of E-cadherin and keratin, contact inhibition in monolayer growth (Danielson et al., 1984) and the ability to differentiate in vitro when plated on the artificial extracellular matrix Matrigel (Roskelley et al., 2000) . Importantly, scp2 cells do not form tumors when injected into syngeneic Balb/c mice (Lochter et al., 1997) . We observed that the expression of activated mutants of M-Ras in scp2 cells resulted in morphological transformation and loss of the epithelial characteristics, together with a gain of mesenchymal markers and the ability to invade Matrigel and form tumors in vivo. These results indicated that the expression of activated M-Ras was sufficient for transformation of a mammary epithelial cell line.
Results

Expression of activated M-Ras caused morphological transformation of murine mammary epithelial cells
We used retroviral infection to express constitutively active mutants of MRas (G22V or Q71L), p21 Ras (G12V H-Ras or Q61K N-Ras) or wild-type M-Ras in scp2 cells. The bi-cistronic vector directed the expression of both the relevant Ras protein and green fluorescent protein (GFP) from the same mRNA. This permitted the use of fluorescence microscopy to identify and observe the behavior of cells expressing these proteins early after retroviral infection and of fluorescenceactivated cell sorting (FACS) to purify them. Inspection of cultures, using fluorescence microscopy within 1 week of infection, showed that cells expressing wild-type M-Ras (Figure 1a ) or GFP alone ( Figure 1b ) exhibited a normal epithelial morphology. In contrast, cells expressing constitutively active mutants of M-Ras (G22V or Q71L) rapidly lost their epithelial characteristics (Figure 1a, b) , adopted an elongated spindle-like shape and grew on top of uninfected epithelial cells, which could be identified by their lack of GFP expression.
We observed that cells with very low levels of fluorescence retained their epithelial shape, implying that a threshold level of expression of activated M-Ras was needed to induce the transformed phenotype. We also noted that those cells transformed by Q71L M-Ras appeared less fluorescent than those transformed G22V M-Ras (Figure 1b) , indicating that lower levels of expression of the Q71L M-Ras mutant were required. This was consistent with our previous observation that a smaller fraction of the G22V mutant is in the GTPbound state (Ehrhardt et al., 2001) , and hence higher levels of expression were required for transformation. We have previously shown that levels of fluorescence correlated with the expression of activated M-Ras using this vector (Ehrhardt et al., 1999) , and have confirmed this correlation for these scp2 cells (data not shown). The expression of activated mutants of p21 Ras (G12V H-Ras or Q61K NRas) in scp2 cells resulted in a morphological transformation similar to that seen with the expression of activated M-Ras (Figure 1a) . However, inspection of cultures by fluorescence microscopy in the first week after infection revealed that the cells that expressed the highest levels of GFP and thus of activated p21 Ras had rounded up and were often vacuolated (Figure 2a) . Moreover, some of the brightest cells were dead or disintegrating. Finally, even 6 days after infection, some of the cells that fluoresced brightly still occurred as single isolated cells. This contrasted with the appearance of parallel cultures containing cells expressing activated M-Ras, where brightly fluorescent cells occurred in clusters of dividing cells.
To further investigate the differences in viability and growth rates between cells expressing activated M-Ras and p21 Ras, we used FACS to purify GFP-positive cells from cultures 4 days after infection with the respective retroviral vectors. We then investigated their growth and viability when cultured under standard conditions in liquid or in agar (Figure 2b-d) . In liquid cultures, the numbers of cells expressing activated p21 Ras increased more slowly than those of cells expressing activated M-Ras, or GFP alone (Figure 2b ). There was also an increased frequency of dead cells in the cultures of cells expressing activated p21 Ras (Figure 2c) . In agar cultures, cells expressing activated p21 Ras exhibited a lower frequency of colony formation than did cells expressing activated M-Ras (Figure 2d ). We concluded that the acute effects of expression of higher levels of activated Q61K N-Ras, or G12V H-Ras, were to inhibit cell growth and promote cell death.
Expression of activated M-Ras resulted in the loss of epithelial markers and induction of mesenchymal markers
The expression of activated M-Ras in scp2 cells resulted in loss of the epithelial markers, E-cadherin, b-catenin and cytokeratin. Thus, whereas in parental scp2 cells or cells expressing GFP alone, E-cadherin and b-catenin outlined sites of cell-cell contact, expression of both proteins was lost in cells expressing activated M-Ras (Figure 3a) . Likewise, whereas cytokeratin, an epithelial intermediate filament, was present in parental scp2 cells and in cells expressing GFP alone, it was absent in scp2 cells expressing G22V M-Ras (Figure 3a) . Moreover, scp2 cells expressing G22V M-Ras expressed vimentin, a mesenchymal intermediate filament (Figure 3a) , which was not detected in parental scp2 cells or in cells expressing GFP alone. We used immunoblotting to confirm that cells overexpressing activated M-Ras exhibited a loss of b-catenin and E-cadherin and an induction of expression of vimentin ( Figure 3b ).
Cells expressing activated M-Ras exhibit continued growth in the absence of serum
Cell-cycle analysis of polyclonal populations of scp2 cells-expressing activated M-Ras (G22V or Q71L) demonstrated that, unlike parental cells, they continued to enter the S phase in the absence of serum. A higher percentage of cells expressing activated M-Ras were in the S/G2 phase (M2) than cells expressing GFP alone (Figure 4 ). This effect was greater in the case of cells expressing Q71L M-Ras than those expressing G22V MRas, consistent with the greater activity of the Q71L MRas mutant already mentioned. Similar results were seen with clones of scp2 cells expressing activated M-Ras (data not shown).
Expression of activated M-Ras inhibited differentiation and promoted invasion of Matrigel
When plated on the artificial extracellular matrix, Matrigel, parental scp2 cells or cells expressing wildtype M-Ras or GFP alone formed small clusters of polarized cells termed 'mammospheres'. In contrast, cells expressing activated M-Ras failed to form mammo- Figure 5 ). Cells expressing activated G12V H-Ras also failed to differentiate in response to Matrigel and formed branched networks similar to those seen with cells expressing activated Q71L M-Ras ( Figure 5 ). We noted that scp2 cells expressing activated G12V H-Ras had a lower tendency to migrate through the Matrigel to the bottom of the dish than those expressing activated M-Ras.
We analysed the ability of cells expressing activated M-Ras or GFP alone, to migrate through a layer of Matrigel overlaying a porous membrane into a lower chamber, where they were permitted to grow. We observed that small numbers of cells expressing activated M-Ras migrated through the Matrigel, whereas cells expressing GFP alone did not. Those cells that migrated through the Matrigel and grew exhibited 
Expression of activated M-Ras in scp2 cells resulted in growth of tumors in immunodeficient mice
To assess tumor formation, we injected scp2 cells expressing isoforms of Ras and GFP, or GFP alone, beneath the abdominal skin of syngeneic Balb/c mice, which were immunoincompetent due to the ablation of Rag-1 genes. The injection of 5 Â 10 5 scp2 cells that expressed Q71L M-Ras or G12V H-Ras gave rise to rapidly growing tumors. The mean mass of tumors expressing Q71L MRas was similar to those expressing G12V H-Ras (Figure 6a ). No tumors were seen in animals injected with cells expressing either GFP alone or wild-type MRas. We also compared the two activating mutations of M-Ras in terms of their ability to drive tumor formation. We injected 1 Â 10 5 cells expressing Q71L M-Ras or G22V M-Ras subcutaneously into mice. At 3 weeks, tumors formed by cells expressing Q71L M-Ras had reached a diameter of 1 cm, and were significantly larger than those formed by cells expressing G22V M-Ras (Figure 6b) .
The tumors that formed at the site of injection of cells expressing activated M-Ras were often associated with prominent networks of blood vessels. In some mice, tumor cells invaded the peritoneal cavity and underwent extensive, transperitoneal spread, forming masses of tumor cells on the mesentery and the capsules of the liver and spleen. We did not observe metastases in the lung.
We noted that mice with large burdens of tumors, whether these expressed activated M-Ras or activated H-Ras, exhibited marked enlargement of the spleen. This was not due to infiltration of the spleen by tumors cells, which could be readily identified by fluorescence microscopy, and occurred whether or not tumor cells were associated with the spleen. The weights of spleens from tumor-bearing mice correlated closely with the weight of the tumor at the injection site (Figure 7) , consistent with the notion that the tumor mass was releasing a systemic factor that stimulated the development of splenomegaly. Histological examination of the spleens revealed increases in the number of neutrophils and their precursors (data not shown). Splenomegaly and granulocytosis have been previously reported in mice bearing murine mammary tumors (Tremblay et al., 1989; Macmanus et al., 1990) . We observed that scp2 cells expressing activated G12V H-Ras exhibited significant activation of ERK compared with cells expressing GFP alone. We also observed the activation of ERK in scp2 cells transformed by Q71L M-Ras, although there was a tendency for the levels of phosphorylated ERK to be lower than in those expressing activated G12V H-Ras (Figure 8a ). Conversely, while cells expressing either isoform of activated Ras exhibited activation of the PI3 kinase path as assayed by phosphorylation of Akt, scp2 cells expressing activated Q71L M-Ras tended to have slightly higher levels of phosphorylated Akt than those expressing activated G12V H-Ras (Figure 8a ). In vitro, the cells were subject to artificial stimuli from the serum and insulin. To evaluate signaling mechanisms in tumor cells in vivo, we examined lysates of tumors derived from scp2 cells expressing either activated M-Ras or activated p21 Ras. Lysates of both types of tumors exhibited phosphorylation of both Akt and ERK (Figure 8b ), although once again there was a tendency for levels of activation of ERK to be higher in the tumors expressing G12V H-Ras. Similar results were seen in two independent experiments, in each of which four individual tumors were analysed.
We also used inhibitors of PI3K (LY 294002) and MEK1 (PD 098059) to assess the contribution of the PI3K and ERK pathways to the transformed phenotype. Incubation for 24 h of monolayer cultures of scp2 cells that had been transformed by either activated MRas or H-Ras with LY 294002 (25 mM), a concentration that blocked the phosphorylation of Akt downstream of PI3 K, resulted in reduced cell viability (data not shown). Similar results were seen with parental cells. Treatment with PD 098059 at a concentration (20 mM) that blocked phosphorylation of ERK did not affect the viability of scp2 cells expressing either activated M-Ras or H-Ras. However, both cell types exhibited an alteration in morphology, with flattening of the spindle-shaped cells typical of the transformed phenotype (data not shown). However, treatment for 24 h with PD 098059 (20 mM) also resulted in some flattening of the epithelial parental scp2 cells. We concluded that expression of activated M-Ras or H-Ras did not abrogate the requirement for PI3K activity for survival or the requirement for activation of the ERK pathway for morphological changes.
Levels of expression of activated M-Ras and p21 Ras in tumors
As the myc epitope tag was present on both Q71L MRas and G12V HRas, the levels of these isoforms present in tumors derived from cells transformed by either isoform of Ras could be compared by immunoblotting tumor lysates for this common epitope tag. By this method, we found that tumors formed by cells expressing either Q71L M-Ras or G12V H-Ras exhibited comparable levels of the respective Ras isoforms (Figure 8b) . Immunoblotting of the tumor lysate with a monoclonal antibody specific for p21 Ras revealed that the levels of exogenous G12V H-Ras (and by extrapolating those of Q71L MRas) were equivalent to those of endogenous p21 Ras (data not shown). In contrast, in tumors formed from scp2 cells expressing G22V M-Ras; the mean levels of G22V M-Ras were higher than those of G12V H-Ras or Q71L M-Ras in the respective tumors (data not shown). This was consistent with the notion that there was selection for higher levels of expression of the 'weaker' G22V M-Ras mutant.
Discussion
These findings demonstrate that the expression of activated M-Ras (but not of wild-type M-Ras) was sufficient for transformation of scp2 murine mammary epithelial cells. This process involved an EMT. Thus, the expression of activated M-Ras resulted in a reproducible loss of epithelial characteristics, including the loss of the ability to form differentiated mammospheres in Matrigel. This was accompanied by the gain of mesenchymal characteristics, together with the ability to invade The fact that cells expressing levels of Q71L M-Ras equivalent to those in tumors expressing G22V M-Ras were not selected for, suggests that there was an optimal level of signaling downstream of active M-Ras and that, at higher expression levels, negative effects supervened. This notion is consistent with our previous findings that IL-3-dependent hematopoietic cells that expressed high levels of activated M-Ras gained the capacity to survive in the absence of IL-3, but grew more slowly than the parental cells in its presence (Ehrhardt et al., 1999) . The signaling paths downstream of M-Ras that are responsible for generating the phenotypes we observed may be complex. Cells expressing activated M-Ras exhibited clear evidence of activation of the ERK and PI3 kinase pathways, both in vitro (Figure 8a ) and, importantly, in the tumors in vivo (Figure 8b ). The observed activation of Akt is consistent with evidence that M-Ras interacts directly with PI3K (Kimmelman et al., 2000) and that expression of activated M-Ras in 3T3 cells (Kimmelman et al., 2000) or hematopoietic cells (Grill and Schrader, 2002) resulted in activation of PI3K and phosphorylation of Akt. In PC12 neuronal cells, M-Ras was a more potent activator of the PI3 kinase pathway than was p21 Ras (Kimmelman et al., 2000) , consistent with our observation that in vitro, cells expressing Q71L M-Ras exhibited slightly higher levels of Akt phosphorylation than cells expressing G12V HRas (Figure 8a ). Thus, it is possible that at least part of the observed activation of Akt reflects direct activation of PI3 K by activated M-Ras.
The mechanism through which the expression of activated M-Ras activated the ERK pathway is unlikely to be direct. Thus, activated M-Ras interacts only weakly with Raf-1 (Kimmelman et al., 1997; Ehrhardt et al., 1999) , and transient expression of activated MRas in fibroblasts was a relatively weak activator of ERK (Kimmelman et al., 1997; Quilliam et al., 1999) .
We have evidence that in scp2 cells expressing G22V MRas, the activation of ERK is dependent on the density at which cells are cultured and is due to an autocrine mechanism that involves hepatocyte growth factor (Zhang, Ward and Schrader, submission). Our observation that inhibition of ERK activation with the pharmacological inhibitor PD 098059 resulted in flattening of cells transformed by activated M-Ras suggested that ERK activity is needed for maintaining aspects of the transformed phenotype. Likewise, our observation that inhibition of the PI3 K pathway in cells transformed by activated M-Ras using the pharmacological inhibitor LY 294002 resulted in decreased viability, indicated that the activity of PI3K was required for cell survival. Thus, both PI3K and ERK activities are likely to be needed to maintain the transformed phenotype of cells expressing activated M-Ras or activated H-Ras.
Another effector of p21 Ras with an established role in oncogenesis is Ral-GDS. As noted, in human cells, Ral-GDS rather than Raf-1 appears to be the critical effector responsible for the transforming ability of activated p21 Ras (Hamad et al., 2002) . However, in contrast to activated p21 Ras, activated M-Ras binds only weakly to Ral-GDS (Ehrhardt et al., 2001) . At least one other member of the Ral-GDS family, RPM, binds to M-Ras although it appears to be a tumor suppressor rather than an oncogene (Ehrhardt et al., 2001) . There are two known M-Ras-specific effectors, RA-GEF2 (Gao et al., 2001 ) and MR-GEF (Rebhun et al., 2000) . Both are Rap GEFs, and could conceivably have a role in M-Ras-induced transformation.
We also expressed activated M-Ras in another murine mammary epithelial cell line (Eph4), but failed to see evidence of morphological transformation in vitro, although cells expressing activated M-Ras did give rise to tumors in vivo (Zhang, unpublished observations). This may be due to the fact that we were unable to achieve a high incidence of retroviral infection, and consequently that the levels of activated M-Ras in the few infected cells were low. It is thus possible that the differences between the results of expressing activated Ras isoforms in scp2 cells and Eph4 cells reflects the relatively low levels of expression in the latter. In support of this notion, Janda et al. (2002b) reported that expression of activated H-Ras in Eph4 cells failed to result in any changes in morphology or growth in liquid cultures. Nevertheless, when they injected Eph4 cells expressing activated H-Ras into mice, tumors formed and these exhibited the hallmarks of EMT (Janda et al., 2002a) . Although they did not report the levels of activated H-Ras present in these Eph4 cells it is possible that these were low, as they too appeared to have difficulty infecting these cells with retroviral vectors.
The bi-cistronic retroviral vector used to express the Ras proteins allowed us to identify a key difference between the effects of expression of activated MRas and p21 Ras that would not have been apparent with conventional protocols, which rely on drug-resistance markers to select cells expressing exogenous Ras. These strategies permit the analysis of only those cells that can survive and grow in the presence of the exogenously expressed Ras. The use of bi-cistronic expression of Ras and GFP enabled the examination of single cells soon after infection by fluorescence microscopy, and revealed the toxic effects of expression of high levels of activated p21 Ras. The toxicity that was evident in scp2 cells expressing high levels of activated p21 Ras, but not of activated MRas, may reflect the higher levels of phospho-ERK observed in scp2 cells expressing activated p21 Ras compared with those observed in cells expressing activated M-Ras (Figure 8a, b) . Overactivity of ERK MAP kinase is known to inhibit cell growth and survival (Pritchard and McMahon, 1997; Woods et al., 1997) through mechanisms that include increases in levels of the cyclin-kinase inhibitor p21 WAF/CIP (Tombes et al., 1998; Fanton et al., 2001) . Another potential inhibitory mechanism could involve the effector of p21 Ras (and M-Ras) RPM (Ehrhardt et al., 2001) . Overexpression of RPM blocks the proliferation of fibroblasts transformed by activated Src or p21 Ras through a mechanism that is activated by p21 Ras, but not by MRas (Ehrhardt et al., 2001) .
M-Ras is ubiquitously expressed and, in particular, mRNA was present in two human mammary cell lines (Ehrhardt et al., 1999) . M-Ras cDNAs are also present in libraries from normal human mammary gland (CGAP database). Expression of M-Ras has been detected in microarray analyses of samples from human breast tumors, normal breast tissue and mammary epithelial cell lines (Perou et al., 2000) . Likewise, analysis of the SAGE database (Boon et al., 2002) indicates that M-Ras expression is present in breast tumors and normal tissue. A unique tag (TCGGGTTTAC) that is present in the human M-Ras gene (Hs.349227) occurred in seven SAGE libraries from human breast samples. The frequency of the tag was higher in lung metastases of a breast carcinoma (12/ 200 000) than in a sample from breast hyperplasia (3/ 200 000).
Our findings extend the range of cell types that can be transformed by the expression of activated M-Ras from hematopoietic cell lines and 3T3-fibroblasts to epithelial cells. This is significant, as cancers of epithelial origin are the most common human tumors, and there is increasing evidence that the signaling mechanisms required for transformation of epithelial cells differ from those needed to transform murine fibroblasts (Pruitt et al., 2002) .
Materials and methods
Cell culture and monolayer growth
Parental scp2 cells and cells expressing exogenous Ras proteins were cultured on plastic dishes in Dulbecco's modified Eagle medium (DMEM) with 4% FCS (Hyclone), gentamycin 50 mg/ ml (Sigma) and bovine insulin 5 mg/ml (Sigma). Parental cells were passaged at a 1 : 4 ratio twice a week. Polyclonal populations were derived by selection in media containing 2 mg/ml puromycin or using a FACS to sort cells expressing GFP. Single cells were sorted into 96-well plates using FACS and clones were expanded. Cell growth was assayed using trypan blue exclusion to count viable cells in triplicate. Similarly, cell death was measured by counting cells stained with 5 mg/ml propidium iodide in triplicate.
Retroviral infection and selection
We used a bi-cistronic retroviral vector (pMX-pie) in which GFP is expressed from the same mRNA as the protein of interest, to overexpress various Ras constructs in the scp2 cell line. Briefly, virus was generated by transient transfection of the packaging cell line BOSC 23 with a helper-free retroviral system (pCLeco) (Naviaux et al., 1996) using lipofectamine. Cell-free viral supernatant was collected at 24-48 h. The efficiency of infection was increased by the addition of polybrene (5 mg/ml) to the viral supernatant and by centrifugation of the cells and viral supernatant at 1800 r.p.m. for 30 min. The pMX-pie constructs encoded Ras isoforms epitope-tagged at the N-terminus with tags from either Myc or hemagglutinin (HA). The level of expression of GFP correlated with the level of expression of the Ras protein, and could be monitored by flow cytometry. The level of Ras expression could be confirmed by immunoblotting with an antibody for the appropriate tag.
Immunohistochemistry
Glass coverslips (18 mm round) were sterilized with ethanol and placed in 12-well plates. Cells were plated at a density of 1 Â 10 5 cells per well and grown until confluent. Coverslips were fixed in methanol at À201C for 20 min and stored in phosphate-buffered saline (PBS) at 41C. Adherens junction markers were quantified using anti-E-cadherin and anti-bcatenin (Pharmingen). Epithelial and mesenchymal markers were quantified using anti-cytokeratin (DAKO Corporation) or antivimentin (Sigma) antibodies. Primary antibodies were detected using appropriate FITC-conjugated secondary antibodies. Images were collected on a BioRad Radience Plus Confocal system and analysed using NIH image.
Cell-cycle analysis
Cells were plated at 100 000/ml of medium in the presence or absence of 4% serum. After 36 h, cells were washed with PBS, detached from the plates using trypsin, and resuspended in Hanks' balanced salt solution with 2% serum, 10 mg/ml of Hoechst 33342 and 5 mg/ml of propidium iodide. DNA content of the GFP-expressing cells was assayed by flow cytometric quantification of the Hoechst fluorescent signal on a Facs Vantage instrument (Becton Dickinson). The percentage of cells in the S/G2 phase was calculated as described previously (Crissman et al., 1985) , and results displayed using Cell Quest software (Becton Dickinson).
Growth of differentiated structures in Matrigel
Dishes were coated with 150 ml of an exogenous basement membrane 'Matrigel' (Becton Dickinson) diluted 1 : 1 with serum-free DMEM at 41C and incubated overnight or for 1 h at 371C. Cells were suspended in DMEM with 1% serum and plated at a density of 1 Â 10 5 per 35-mm dish. Dishes were incubated at 371C for 24-48 h. Plates were inspected by inverted microscopy on an Olympus 1 Â 70. Phase contrast and fluorescence digital images were taken using a Sensys camera at Â 200 magnification.
Colony assay
To measure anchorage-independent growth, cells were detached with trypsin and resuspended in DMEM with 4% serum to a final concentration of 1000 cells per ml. Plates were prepared with a coating of 1% agar to prevent cells from attaching to the bottom of the dish, and then overlaid with a cell suspension in either 1.25% methylcellulose (Stem cell) or 0.3% agar (Becton Dickinson). Plates were incubated for 2 weeks at 371C and colonies were counted using a dissecting microscope (Leica MZFLIII).
Tumor formation
We used immunodeficient Rag-1 À/À Balb/c mice (Jackson Laboratories) to avoid any immunogenic response to GFP. Cells were diluted to 1-5 Â 10 5 per 100 ml in PBS per mouse, and injected subcutaneously into the lower abdomen of groups of four mice. External tumor growth was assessed every other day and all mice were killed when at least one animal had a tumor mass that reached 1 cm in diameter. Tumor masses were dissected out and weighed, as were spleens. Samples of the liver, spleen, lung and kidney were taken for histological examination. Mice were also examined for evidence of metastasis using a fluorescence dissecting microscope (Leica MZFLIII).
Immunoblotting
Cell lysates were made from cell suspensions, at a concentration of 1 Â 10 6 cells per 100 ml of solubilization buffer. Solubilization buffer contained 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% glycerol, 1% NP40, 5 mM EDTA, protease inhibitors (Pharmacia mini cocktail) and phosphatase inhibitors (1 mM Na 4 VO 3 , 5 mM NaF, 1 mM NaMoO 4 Á 2H 2 O and 5 mM C 3 H 7 O 6 PNa 2 ). Protein levels were assayed (BCA Pierce) and 100 mg of total protein was loaded for each sample. Proteins were separated on 10% SDS-polyacrylamide gel electrophoresis (PAGE) gels. The gels were then transferred onto nitrocellulose membranes using a semi-dry transfer apparatus (Bio Rad) and blocked overnight at 41C with 5% bovine serum albumin (BSA). The membranes were probed with primary antibodies at room temperature for 1 h, washed (TBS with 0.05% NP-40) and exposed to the relevant secondary antibodies conjugated with HRP (DAKO). The levels of Ras protein expression were detected using anti-HA (12CA5 produced within our laboratory) or anti-myc (9B11 Cell Signaling Technology). The activation state of ERK or Akt was determined using phospho-specific antibodies (Cell Signaling Technology). Equivalence of loading was ascertained by stripping and reblotting with either anti-ERK or anti-b-actin antibodies (Santa Cruz). The membranes were washed and bands were visualized using chemiluminescence (ECL Amersham Pharmacia) and exposure to film (X-OMAT Kodak).
